Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Tumour Regulatory Molecules as Markers of Malignancy in Pancreatic Cystic Lesions

NCT03536793 is registered in ClinicalTrials.gov with Hull University Teaching Hospitals NHS Trust as lead sponsor.

NCT NCT03536793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03536793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Tumour Regulatory Molecules as Markers of Malignancy in Pancreatic Cystic Lesions
Lead sponsor
Hull University Teaching Hospitals NHS Trust
Phase
Observational
Overall status
Recruiting
Start date
October 24, 2018
Completion date
February 28, 2029
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of pancreas, pancreas cyst